Literature DB >> 21313713

Myasthenia Gravis.

I T Draper.   

Abstract

Entities:  

Year:  1965        PMID: 21313713      PMCID: PMC2483017          DOI: 10.1136/pgmj.41.476.356

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  36 in total

1.  Neurological syndromes associated with carcinoma: the carcinomatous neuromyopathies.

Authors:  R BRAIN; R A HENSON
Journal:  Lancet       Date:  1958-11-08       Impact factor: 79.321

2.  Changes in serum complement activity in patients with myasthenia gravis.

Authors:  W L NASTUK; O J PLESCIA; K E OSSERMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

3.  Treatment of anticholinesterase intoxication with oximes.

Authors:  D GROB; R J JOHNS
Journal:  Neurology       Date:  1958-12       Impact factor: 9.910

4.  A study of curare action with an electrical micromethod.

Authors:  L DEL CASTILLO; B KATZ
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-05-07

5.  Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors.

Authors:  L M EATON; E H LAMBERT
Journal:  J Am Med Assoc       Date:  1957-03-30

6.  An evaluation of thymectomy in myasthenia gravis.

Authors:  J A SIMPSON
Journal:  Brain       Date:  1958-03       Impact factor: 13.501

7.  Sensitivity of myasthenia gravis patients to tubocurarine and decamethonium.

Authors:  E W PELIKAN; J E TETHER; K R UNNA
Journal:  Neurology       Date:  1953-04       Impact factor: 9.910

8.  Effect of tensilon in myasthenia gravis.

Authors:  M R WESTERBERG; K R MAGEE; F E SHIDEMAN
Journal:  Neurology       Date:  1953-04       Impact factor: 9.910

9.  Myasthenia gravis and pregnancy.

Authors:  D FRASER; J W TURNER
Journal:  Lancet       Date:  1953-08-29       Impact factor: 79.321

10.  Course and management of myasthenia gravis.

Authors:  D GROB
Journal:  J Am Med Assoc       Date:  1953-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.